Heparin Market Size, Share, Growth, Industry Analysis by Trends and Forecast Report 2027

0 30
Avatar for Neha420
3 years ago

The global heparin market size is expected to reach USD 11.43 billion by 2027, exhibiting a CAGR of 3.9% during the forecast period. The increasing cases of cardiovascular diseases such as deep vein thrombosis & pulmonary embolism are expected to spur demand for heparin in the forthcoming years, states Fortune Business Insights, in a report, titled “Heparin Market Size, Share & Industry Analysis, By Product Type (Unfractionated Heparin (UFH), and Low Molecular Weight Heparin (LMWH)), By Source (Bovine, and Porcine), By Application (Deep Vein Thrombosis & Pulmonary Embolism, Atrial Fibrillation, Heart Attacks, Stroke, and Others), By Route of Administration (Intravenous Infusion, and Subcutaneous Injection), By End User (Hospitals & ASCs, Clinics, and Others), and Regional Forecast, 2020-2027.” The market size stood at USD 8.39 billion in 2019.

The report on the heparin market reveals:

  • Prominent insights into the industry

  • Noteworthy data about major companies

  • Emerging trends and drivers

  • Comprehensive analysis of the segments

  • COVID-19 effect on the industry

For more information visit : https://www.fortunebusinessinsights.com/heparin-market-104447

Minimal Impact on the Market During COVID-19

The limitations on non-essential medical procedures and consultations has had a drastic impact on the global market amid COVID-19. The healthcare industry has observed a decline in other medical services besides coronavirus. The increased emphasis on COVID’s vaccine has reduced the demand for other therapeutics. Furthermore, the lack of supply and production of heparin will simultaneously limit the scope of the market. However, government initiatives, including heavy investments and free medical aid will influence the healthy growth of the market in the time of the pandemic.

High Adoption of Advanced Products to Boost Market in North America

The market size in North America stood at USD 4.28 billion in 2019. The growth in the region is attributed to the prevalence of cardiovascular diseases such as pulmonary embolism. The higher adoption of advanced heparin products will have an excellent effect on the market in the region. The increasing healthcare expenditure is expected to foster the healthy growth of the market in North America.

The presence of major companies can further enhance the development of the market in the region. Europe is expected to hold the largest share owing to the acceptance of technologically advanced products in the region. The rising number of patients suffering from a range of cardiovascular diseases will further spur opportunities in the region. Asia Pacific is expected to experience a rapid growth rate owing to the growing patient population. The surging healthcare expenditure in the developing nations will have a tremendous effect on the market in Asia Pacific.

Key Development:

May 2019: Pfizer, Inc. announced that it has received the approval from the U.S. FDA for the administration of its heparin product offering, Fragmin to minimize the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients aged one month and above.

The Report Lists the Key Companies in the Heparin Market:

  • Opocrin S.p.A. (Formigine, Italy)

  • Baxter (Deerfield, U.S.)

  • Pfizer Inc. (New York, U.S.)

  • Bioiberica S.A.U. (Barcelona, Spain)

  • Fresenius SE & Co. KGaA (Bad Homburg, Germany)

  • Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (Shijiazhuang, China)

  • B. Braun Melsungen AG (Melsungen, Germany)

  • Dr. Reddy’s Laboratories Ltd. (Hyderabad, India)

  • LEO Pharma A/S (Ballerup, Denmark)

  • Aspen Holdings (Durban, South Africa)

  • Other Players

Global Heparin Market Segmentation :

By Product Type

  • UFH

  • LMWH

By Source

  • Bovine

  • Porcine

By Application

  • Deep Vein Thrombosis & Pulmonary Embolism

  • Atrial Fibrillation

  • Heart Attacks

  • Stroke

  • Others

By Route of Administration

  • Intravenous Infusion

  • Subcutaneous Injection

By End-User

  • Hospitals & ASCs

  • Clinics

  • Others

By Geography

  • North America

    • By Product Type

    • By Source

    • By Application

    • By Route of Administration

    • By EndUser

    • By Country

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/heparin-market-104447

SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies

  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.

  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility

  • Number of procedures and average price of procedures

  • Replacement rate and pricing of capital equipment

  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities

  • Market & technological trends, new product developments, product pipeline.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

1
$ 0.00
Avatar for Neha420
3 years ago

Comments